Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (121-130 of 3,133) with videos related to

Pageof 314
Sort By:
Cytotherapy|May 15, 2003
Cytokine flow cytometry: multiparametric approach to immune function analysisS A Ghanekar, H T Maecker
Cytotherapy|February 6, 2003
BM-derived stem cells for the treatment of nonhematopoietic diseasesD S Krause
Cytotherapy|February 6, 2003
Multipotential stem cells and 'side population' cellsM A Goodell
Cytotherapy|February 6, 2003
False positive endotoxin results in a DC product caused by (1-->3)-beta-D-glucans acquired from a sterilizing cellulose filterJ Anderson, M Eller, M Finkelman, et al.
Cytotherapy|November 19, 2002
Meeting Report. Bone Marrow Transplant Scientists' Association of AustraliaA Trickett
Cytotherapy|August 27, 2002
Autologous hematopoietic transplantation for low-grade lymphomasJ G Gribben
Cytotherapy|August 13, 2002
Pharmacokinetics of CAMPATH-1H in BMT patientsP Rebello, K Cwynarski, M Varughese, et al.
Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.
Cytotherapy|August 13, 2002
Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokinesJ C Young, K Lin, M Travis, et al.
Cytotherapy|August 13, 2002
The CD52 antigen and development of the CAMPATH antibodiesG Hale
Pageof 314

Showing results (121-130 of 3,133) with videos related to

Sort By:
Pageof 314
Cytotherapy|May 15, 2003
Cytokine flow cytometry: multiparametric approach to immune function analysisS A Ghanekar, H T Maecker
Cytotherapy|February 6, 2003
BM-derived stem cells for the treatment of nonhematopoietic diseasesD S Krause
Cytotherapy|February 6, 2003
Multipotential stem cells and 'side population' cellsM A Goodell
Cytotherapy|February 6, 2003
False positive endotoxin results in a DC product caused by (1-->3)-beta-D-glucans acquired from a sterilizing cellulose filterJ Anderson, M Eller, M Finkelman, et al.
Cytotherapy|November 19, 2002
Meeting Report. Bone Marrow Transplant Scientists' Association of AustraliaA Trickett
Cytotherapy|August 27, 2002
Autologous hematopoietic transplantation for low-grade lymphomasJ G Gribben
Cytotherapy|August 13, 2002
Pharmacokinetics of CAMPATH-1H in BMT patientsP Rebello, K Cwynarski, M Varughese, et al.
Cytotherapy|August 13, 2002
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cellsJ Burgess, B Mills, M Griffith, et al.
Cytotherapy|August 13, 2002
Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokinesJ C Young, K Lin, M Travis, et al.
Cytotherapy|August 13, 2002
The CD52 antigen and development of the CAMPATH antibodiesG Hale
Pageof 314